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Objective: To assess the inﬂuence of baseline score on concordance between the Minimal Clinically
Important Difference (MCID) and Patient Acceptable Symptom State (PASS) estimates obtained on per-
sons following total knee arthroplasty (TKA).
Design: Patients scheduled for TKA in 15 hospitals in Spain were recruited and provided pre-operative
and 1-year postoperative Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Pain and Function scores. 1 year following surgery, patients completed questionnaires that determined
the importance of any changes in status since surgery as well as the extent of satisfaction with the 1-year
outcome. Kappa (k) was used to determine the extent of concordance between MCID and PASS measures
for the entire sample and after splitting the sample based on quartiles of the baseline WOMAC scores.
Results: A total of 923 patients participated in the study. The extent of concordance between MCID and
PASS without regard to baseline score was k ¼ 0.41 (95% Conﬁdence Interval (CI) ¼ 0.36, 0.47) for
WOMAC Function and after stratifying baseline scores into quartiles, k ¼ 0.72 (95%CI ¼ 0.68, 0.77).
Similar estimates were obtained for WOMAC Pain.
Conclusions: Baseline score has substantial inﬂuence on the extent of concordance between MCID and
PASS for patients undergoing TKA. Clinicians should account for baseline score when interpreting either
MCID or PASS and the extent to which these measures agree. These ﬁndings have potential to inﬂuence
the interpretation of outcome following TKA.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Two commonly recommended evidence-based methods for
judging response to treatment are the Minimal Clinically Important
Difference (MCID), also referred to as Minimal Clinically Important
Improvement (MCII) and the Patient Acceptable Symptom State
(PASS)1. These approaches are conceptually distinct but comple-
mentary. The MCID (or MCII) describes the magnitude of change
associated with patient-perceived important change with treat-
ment while the PASS describes patients' satisfaction or accept-
ability with an outcome at a point in time following an
intervention. Some have described MCID as a journey2 that results
in the patient “feeling better”3 while PASS equates to an acceptable
destination and “feeling good” following treatment.: D.L. Riddle, Otto D. Payton
rthopaedic Surgery, Virginia
4, USA. Tel: 1-804-828-0234;
osakidetza.net (A. Escobar),
ternational. Published by Elsevier LThe patient's baseline score has been repeatedly shown to be an
important modiﬁer of both MCID and PASS estimates in several
studies of persons with knee osteoarthritis (OA) (3e7). Patients
whose knee pain is worse prior to treatment, for example, tend to
perceive larger changes in pain as being important and they tend to
be satisﬁed with greater pain following treatment as compared to
persons with less pre-treatment pain. An important line of inquiry
is to determine the extent to which MCID and PASS estimates are
equivalent. That is, if a patient achieves the MCID, how often does
this same patient achieve PASS? If these two approaches align at
the level of the individual, interpretation of outcome would be
much simpler and clinicians would only need to use a single
approach. When PASS and MCID do not agree for a patient, say the
patient does notmeet theMCID but achieves PASS, interpretation is
more nuanced and potentially confusing for both the clinician and
patient. For example, which of these two attributes is more
important or should they be weighted the same?
Tubach and colleagues have suggested that MCID and PASS are
equivalent for persons with knee OA in that the MCID subtractedtd. All rights reserved.
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for baseline score3. A limitation of the approach by Tubach and
colleagues is the use of group-basedmethods for comparing PASS to
MCID. Group means may be similar but there may be substantial
discordance between PASS and MCID at the level of the individual.
Maxwell and colleagues, on the other hand, reported a third of pa-
tients undergoing total knee arthroplasty (TKA) were discordant on
PASS andMCID estimates4. A limitation of the approach byMaxwell
and colleagues is that baseline score was not adjusted for in the
analysis. Baseline score inﬂuences both PASS and MCID3,5e7.
The MCID and PASS are commonly recommended methods for
judging response to treatment both in clinical practice8 and in
clinical trials9. However, the literature has not established whether
these alternative methods of judging outcome produce similar
ﬁndings at the level of individual patients following TKA. If MCID
and PASS estimates are different at the individual patient level,
clinicians should assess both given the distinct inferences associ-
ated with the two approaches. The purpose of our study was to
assess the impact of baseline stratiﬁcation on the extent to which
either Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC) Function or WOMAC Pain PASS and MCID esti-
mates are concordant for persons undergoing TKA.Methods
We have combined two cohorts of patients waiting for TKA,
with similar sample characteristics, and which have been described
elsewhere10. Consecutive patients placed on the waiting list to
undergo primary TKA for OA and managed in the 15 participant
hospitals were eligible for the study. All patients received a letter
informing them about the study and asking for their voluntary
participation. Questionnaires were sent to consenting patients at
baseline and 12 months post-surgery. Of the 1616 persons who
were offered participation, a total of 923 (57.1%) completed all 12-
month questionnaires. The Institutional Review Boards of the
Hospitals approved the studies.
We used the WOMAC, a disease-speciﬁc, self-administered
questionnaire11. It is a multidimensional scale made up of 24 items
grouped into three dimensions: pain (5 items), stiffness (2 items),
and physical function (17 items). Our focus in the current study was
the WOMAC Pain and Function dimensions. We used the Likert
version with ﬁve response levels for each item, representing
different degrees of intensity (none, mild, moderate, severe or
extreme) and that were scored from 0 to 4. The ﬁnal scores were
determined by adding the corresponding items for each dimension,
and standardizing to a range of values from 0 to 100. We used the
reverse option, where 0 represents the worst and 100 the best
status. The WOMAC has been translated and validated into
Spanish12.Statistical analysis
Descriptive statistics included frequencies and percentages for
categorical variables and means and standard deviations (sd) for
continuous variables. MCID has been deﬁned1 as the smallest dif-
ference between the scores in a questionnaire that the patient
perceives to be beneﬁcial. All patients had to answer two questions,
raw transition items (RTI), about their improvement or deteriora-
tion, one about pain and another about function 1 year after TKA.
The ﬁve possible responses were “a great deal better”, “somewhat
better”, “equal”, “somewhat worse” and “a great deal worse”. The
MCID was estimated for pain and function by the mean change
score for those patients who declared changes “somewhat better”
in the RTI regarding their pain and function taking the differencebetween the score at 1 year and at the baseline. The usefulness of
our RTI in establishing the MCID has been previously described10.
Following the paper of Tubach et al.13, we used the concept of
PASS. It has been studied using the question: “If you had to be the
rest of your life with the symptoms you have now, how would you
feel?” In lieu of a “yes” or “no” response as deﬁned by Tubach
et al.13, categories in our study were very satisﬁed, somewhat
satisﬁed, somewhat dissatisﬁed and very dissatisﬁed. Patients who
were “very satisﬁed” or “somewhat satisﬁed” were considered as
satisﬁed while the remainder was considered as unsatisﬁed (Yes/
No). As we have used the reverse option for WOMAC scores where
0 represents the worst status and 100 the best possible status, we
deﬁned the PASS as the twenty-ﬁfth percentile of the ﬁnal score at
1 year instead of the seventy-ﬁfth percentile. We analyzed the
extent of agreement between PASS and MCID by means of kappa
coefﬁcient (k) along with 95% Conﬁdence Intervals (CIs). Analyses
were performed globally (i.e., without baseline score stratiﬁcation)
and according to baseline severity quartiles. We stratiﬁed by
quartiles because our relatively large sample size allowed for
reasonably narrow conﬁdence limits. The inﬂuence of the baseline
score on concordance was judged by the extent to which, if any, the
95% CIs of the k coefﬁcients for one measure (e.g., baseline scores
analyzed in quartiles, k for WOMAC Function) demonstrated over-
lap with the point estimate of the other measure (e.g., global k for
WOMAC Function). All statistical analyses were performed using
SPSS version 17 and Conﬁdence Interval Analysis (CIA) v.2.2.
Results
We had 923 patients in our sample, 70% were female and the
average age was 71.6 (sd ¼ 6.8) years. Average WOMAC Function
scores were 38.7 (sd¼ 17.5) at baseline and 70.7 (sd¼ 20.10) 1-year
following TKA. The WOMAC Pain average score prior to TKA was
44.5 (sd ¼ 18.1) at baseline and 78.5 (sd ¼ 18.3) 1-year later. Global
and baseline scores analyzed in quartiles for MCID and PASS scores
are reported in Table I and the percentage of patients in each
combination MCID/PASS subgroup and global scores along with k
coefﬁcients for WOMAC Pain and Function scales are reported in
Table II. Kappa (k) for the global MCID and PASS scores was 0.41
(95%CI ¼ 0.36, 0.47) for WOMAC Function and 0.46 (95%CI ¼ 0.40,
0.52) for WOMAC Pain. For the baseline scores analyzed in quar-
tiles, MCID and PASS scores, k for WOMAC Function was 0.72 (95%
CI ¼ 0.68, 0.77) and 0.75 (95%CI ¼ 0.70, 0.79) for WOMAC Pain.
Additional analyses of the MCID and PASS are reported in the on-
line Appendix.
Discussion
Interpreting changes in patient status following TKA is most
commonly judged using MCID and/or PASS. Both potentially pro-
vide useful information regarding either the improvement/wors-
ening since surgery (MCID) or the ﬁnal outcome status (PASS).
These measures, although complementary can sometimes provide
conﬂicting information and the literature is unclear on how com-
mon conﬂicting results occur. We found that adjustment for base-
line status is critically important whenmaking interpretations from
MCID and PASS estimates as a composite indicator of both journey
and destination outcomes following TKA. Point estimates of the
extent of concordance along with 95% CIs were substantially higher
when baseline scores were accounted for as compared to global
scores, as seen in Table II. When a clinician accounts for baseline
scores, agreement between MCID and PASS is substantial14 and
disagreement is infrequent. As noted in Table I, the magnitude of
PASS and MCID estimates are substantially inﬂuenced by baseline
score quartile. For example, the WOMAC Function MCID is 47.5 for
Table I
WOMAC Pain and Function scores, MCID and PASS scores for total sample and by quartiles of baseline severity
Quartile 1 (worst pain
or functional loss)
Quartile 2 Quartile 3 Quartile 4 (least pain
or functional loss)
Global*
Quartiles scores <26.5 26.5e38.3 38.4e50.0 >50.0 e
WOMAC Function
Baseline score 16.7 (15.8e17.6) 33.0 (32.6e33.5) 44.9 (44.4e45.3) 61.6 (60.5e62.7) 38.7 (37.5e39.7)
PASS twenty-ﬁfth (95% CI) 58.8 (54.4e63.2) 64.7 (61.8e67.6) 69.1 (67.6e72.1) 72.1 (67.7e75.0) 66.2 (64.7e67.7)
MCID mean (95% CI) 47.5 (43.4e51.6) 37.2 (34.7e39.7) 27.6 (24.6e30.7) 15.9 (13.3e18.4) 32.4 (30.5e34.2)
Quartiles scores <30.0 30.0e45.0 45.1e55.0 >55.0 e
WOMAC Pain
Baseline score 20.7 (19.5e21.9) 39.6 (39.2e40.1) 51.1 (50.7e51.6) 67.6 (66.5e68.8) 44.5 (43.3e45.6)
PASS twenty-ﬁfth (95% CI) 70.0 (65.0e75.0) 75.0 (70.0e80.0) 75.0 (70.0e80.0) 80.0 (75.0e85.0) 75.0 (70.0e80.0)
MCID mean (95% CI) 47.9 (43.6e52.3) 32.2 (29.1e35.2) 25.1 (22.5e27.7) 12.4 (9.2e15.5) 29.0 (27.0e31.1)
* Global scores did not account for baseline WOMAC score severity.
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score quartile. If a clinician does not account for baseline score,
clinical interpretation will suffer and conﬂicting ﬁndings among
PASS and MCID will be more common. While we studied the MCID
and PASS of self-reported measures, these methods for interpreting
changes over time also are relevant for performance measures
which are commonly conducted on persons with TKA.
Ours is not the ﬁrst study to quantify the importance of baseline
score when interpreting outcome. Davis and colleagues, for
example, found that misclassiﬁcation bias increases if the baseline
score is not accounted for when interpreting change (i.e., MCID) in
patients following TKA6. Baseline status is an important predictor of
both change and ﬁnal outcome and our study, for the ﬁrst time,
demonstrates the important role of baseline status in interpreting
MCID and PASS concordance for individual patients undergoing
TKA. Others have reported on similarities between MCID and PASS
estimates for groups of patients3,7 but the utility of this information
is limited when applied to individuals.
Maxwell and colleagues compared WOMAC PASS and MCID
estimates and found a 67% agreement for PASS and MCID measures
for 228 patients with TKA. The authors did not account for baseline
scores. We calculated kappa (k) from this data and found a k ¼ 0.37
(95%CI ¼ 0.26, 0.49). This estimate was very similar to our global
comparison of MCID and PASS (k ¼ 0.41 (95%CI ¼ 0.36e0.47)). Our
results combined with the ﬁndings of Maxwell and colleagues
provide consensus evidence indicating that PASS and MCID show
only moderate agreement if baseline scores are not accounted for.
Our estimates of PASS/MCID concordance for our analyses of
baseline quartile scores support the notion that clinicians shouldTable II
Percentage of patients in each combination of PASS andMCID and kappa coefﬁcients
for WOMAC Pain and WOMAC Function
PASS/MCID
Total sample cut-off Cut-off by quartiles
WOMAC Function
PASS þ MCID þ* 41.0% 52.6%
PASS þ MCID y 23.0% 11.9%
PASS  MCID þ 6.8% 1.5%
PASS  MCID  29.2% 34.0%
Kappa (95%CI) 0.41 (0.36e0.47) 0.72 (0.68e0.77)
WOMAC Pain
PASS þ MCID þ 54.4% 62.3%
PASS þ MCID  16.3% 8.2%
PASS  MCID þ 7.8% 2.7%
PASS  MCID  21.5% 26.7%
Kappa (95%CI) 0.46 (0.40e0.52) 0.75 (0.70e0.79)
* PASS/MCID þ: patients who attained cut-off scores.
y PASS/MCID : patients who did not reach the cut-off scores.routinely account for baseline scores for both PASS and MCID when
making comprehensive judgments about progress and outcome
following TKA. The evidence demonstrating the role of baseline
score in inﬂuencing MCID estimates3,6,10 and PASS estimates15
combined with our evidence supporting the role of baseline score
on estimates of concordance between PASS and MCID make a
compelling case for the routine use of baseline scores by both cli-
nicians and researchers in interpreting changes and outcomes
following TKA.
While we found good concordance between MCID and PASS, we
still endorse use of both estimates in daily practice because while
agreement was strong (i.e., 86.6% agreement and k ¼ 0.72 for
WOMAC Function and 89% agreement and k ¼ 0.75 for WOMAC
Pain), there will be some patients inwhom there is discordance. For
those patients in whom discordance exists, the clinician will need
to make clinical judgments separately for MCID and PASS and
consider possible reasons for why one indicator was met and the
other was not. Importantly, our study was not designed to deter-
mine whether MCID or PASS is more important for clinical de-
cisions. Until consensus is reached among key arthroplasty
stakeholders on relative importance of PASS vs MCID, it is our
opinion that both indicators of outcome be used routinely in clin-
ical practice to ascertain a comprehensive understanding of likely
surgical effects.Contributions
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